netFormulary Berkshire West NHS NHS
Royal Berkshire NHS Foundation Trust
Berkshire Healthcare NHS Foundation Trust
Berkshire West Clinical Commissioning Group
 
 Search
 Results

Looking for Rituximab found 16 matches

Formulary items 2 matches
Sub Section Title / notes 1 match
   
Formulary BNF Category
  Cytotoxic Drug  Rituximab  (MabThera / Truxima) Rituximab and alemtuzumab - 08.02.03
  Rituximab (rheumatology)  (MabThera / Truxima) Drugs affecting the immune response - 10.01.03
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA 137: Lymphoma (follicular non-Hodgkins) - rituximab (08.02.03)
link in drug section NICE TA 174: Leukaemia (chronic lymphocytic, first line) - rituximab (08.02.03)
link in drug section NICE TA 193: Leukaemia (chronic lymphocytic, relapsed) - rituximab  (08.02.03)
link in drug section NICE TA 195 - Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor (10.01.03)
link in drug section NICE TA 195 - Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor (10.01.03)
link in drug section NICE TA 195 - Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor (10.01.03)
link in drug section NICE TA 195 - Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor (10.01.03)
link in drug section NICE TA 226 - Rituximab for the first-line maintenance treatment of follicular non-Hodgkin’s lymphoma (08.02.03)
link in drug section NICE TA 243: Rituximab for the first-line treatment of stage III-IV follicular lymphoma (08.02.03)
link in drug section NICE TA 308 - Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis (08.02.03)
link in drug section NICE TA 472: Obinutuzumab with bendamustine for treating follicular lymphoma refractory to rituximab (08.01.01)
link in drug section NICE TA 472: Obinutuzumab with bendamustine for treating follicular lymphoma refractory to rituximab (08.01.05)
link in drug section NICE TA 561: Venetoclax with rituximab for previously treated chronic lymphocytic leukaemia (08.01.05)

SubSection Titles / notes  
Rituximab and alemtuzumab - (08.02.03)

 

netFormulary